Skip to main content
blog_bg

Whitepaper

Direct-to-Patient (D2P): Clinical Supplies for Expanded Access

D2P services have a main motto which is on ‘Patient Centricity’ that would help in increase patient participation and retention in any clinical trial. This D2P support will be highly beneficial for clinical trials with drug therapies focused on Orphan Indications, Novel Therapies, Geriatric patient population, Emergency Situations and for Expanded Access Programs (EAPs) also called as ‘Compassionate Use Programs (CUPs)’ for unmet medical needs. Expanded Access is for individual patients, including for emergency use, for intermediate-size patient populations, and for widespread use.

To know in detail download your copy now.

mirt-direct-to-patient-D2P-clinical-supplies-for-expanded-access

    The First Step

    Let's talk about how DDi can help you